HYDROXYPROGESTERONE CAPROATE
Non Excipient
Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
---|---|---|---|---|---|---|
429.0 | 6.0 | 0 | 4 | 60.0 | 6 | 0.81 |
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 42 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
Code | Date | Title | Phase | Status |
---|---|---|---|---|
NCT01899846 | 2013-07-01 | Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood | Phase 1 | Completed |
NCT01317225 | 2011-06-01 | Prevention of Preterm Labor in Patients With a Previous Episode of Threatened Preterm Labor With Progesterone | Phase 3 | Recruiting |
NCT00809939 | 2010-12-01 | 17 Alfa Hydroxyprogesterone Caproate Versus Natural Progesterone for the Prevention of Preterm Labor | Phase 3 | Active, Not Recruiting |
NCT01050647 | 2010-02-01 | Progesterone for the Management of Preterm, Premature Rupture of the Membranes: A Randomized Controlled Trial. | Phase 1/Phase 2 | Active, Not Recruiting |
NCT01004029 | 2009-10-01 | Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery | Phase 3 | Recruiting |
NCT00439374 | 2007-04-01 | RCT of Progesterone to Prevent Preterm Birth in Nulliparous Women With a Short Cervix | Phase 3 | Terminated |
NCT00141908 | 2006-10-01 | Prevention of Preterm Delivery in Twin Pregnancies by 17 Alpha-hydroxyprogesterone Caproate | Phase 2 | Completed |
NCT00331695 | 2006-06-01 | Efficacy of 17 Alpha-hydroxyprogesterones Caproate for the Prevention of Preterm Delivery | Phase 4 | Completed |
NCT00135902 | 2005-02-01 | Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in High Risk Pregnancies | Phase 3 | Completed |
NCT00163020 | 2004-11-01 | 17OHP for Reduction of Neonatal Morbidity Due to Preterm Birth (PTB) in Twin and Triplet Pregnancies | Phase 2/Phase 3 | Completed |
NCT00099164 | 2004-04-01 | Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS) | Phase 3 | Completed |